Sinal Hiperdenso da ACM no AVC
Enviado por
gustvoSinal Hiperdenso da ACM no AVC
Enviado por
gustvoCommon questions
Com tecnologia de IAKey factors affecting the decision to administer thrombolysis include the onset time (within 4.5 hours of symptom onset), absence of contraindications such as a history of hemorrhagic stroke, recent trauma or surgery, current anticoagulation therapy, or significant bleeding risks. Additionally, the severity of the stroke should be assessed using the NIHSS score to ensure eligibility for thrombolysis. Relative contraindications may include minor stroke scales, recent gastrointestinal or genitourinary surgery, and pregnancy .
Major risk factors for ischemic stroke include age, vasculopathies, atherosclerosis, sedentary lifestyle, excessive alcohol consumption, obesity, hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, and a history of myocardial infarction or transient ischemic attacks. These factors contribute to pathogenesis by promoting conditions like atherosclerotic plaque formation, leading to vessel narrowing and potential thrombosis, or conditions like atrial fibrillation which increase the risk of cardiac emboli traveling to cerebral vessels. Hypertension can damage blood vessel walls, and diabetes can lead to microvascular changes, elevating stroke risk .
In emergency management of acute stroke, non-contrast CT scans are commonly used to quickly rule out hemorrhagic stroke, due to their rapidity, availability, and cost-effectiveness. They can also identify subtle signs of ischemia such as the hyperdense middle cerebral artery sign or loss of sulcal markings. Magnetic Resonance Imaging (MRI) can be employed for detecting ischemic strokes, especially if the onset occurred less than 6 hours prior. MRI is more sensitive than CT for identifying acute ischemia and penumbra areas but is less frequently available in emergency settings .
Preventive measures for individuals at high risk of ischemic stroke include lifestyle modifications such as increased physical activity, a balanced diet low in saturated fats and rich in fruits and vegetables, smoking cessation, and reducing alcohol consumption. Medical control of risk factors like hypertension, diabetes, and dyslipidemia is crucial, often involving medications such as antihypertensives, statins, and anticoagulants for those with atrial fibrillation. Regular monitoring and healthcare visits can help maintain optimal management of conditions that elevate stroke risk .
The use of alteplase (rtPA) in treating acute ischemic stroke is limited by strict time windows and contraindications, such as recent surgeries, coagulopathies, or uncontrolled hypertension, which can increase the risk of serious bleeding. Logistic challenges include ensuring rapid patient evaluation and imaging to determine eligibility within the 4.5-hour time frame. Additionally, careful monitoring for adverse effects, such as intracranial hemorrhage during and after administration, poses significant challenges in emergency settings. These constraints can limit rtPA's applicability and necessitate precise risk-benefit assessments before use .
The Circle of Willis is a critical structure in cerebral circulation, comprising the primary arteries that supply the brain. If a major artery such as the internal carotid or vertebral arteries becomes occluded, the Circle of Willis provides collateral circulation pathways through its connections, potentially reducing the severity of ischemic damage during a stroke. However, variability in its structure can influence the extent to which collateral circulation can prevent stroke symptoms . The anterior and middle cerebral arteries, which branch from the internal carotid, have significant roles due to their size and substantial territory covered, making blockages in these arteries particularly detrimental .
The primary types of stroke are ischemic stroke and hemorrhagic stroke. An ischemic stroke occurs due to an acute occlusion of an intracranial vessel, leading to reduced blood flow to the corresponding region of the brain it supplies. This can be caused by thrombosis or embolism, with cardioembolic causes being the most common etiological factor. Conversely, a hemorrhagic stroke occurs due to bleeding within the brain, often caused by rupture of a blood vessel, leading to direct pressure on brain tissue and disruption of normal blood flow. The pathophysiology of ischemic strokes involves blocked blood flow, while hemorrhagic strokes involve bleeding .
The NIHSS score helps quantify the severity of stroke symptoms, serving as a standardized method to assess initial neurological deficits and chart progress or decline. A higher NIHSS score indicates greater severity, potentially guiding therapeutic decisions such as thrombolysis eligibility. The scale evaluates different domains, including consciousness, speech, and motor skills, thereby providing a comprehensive picture of the patient's neurological status. Regular scoring helps monitor treatment efficacy, with significant changes prompting reevaluations or adaptations in management .
Post-thrombolysis management includes close monitoring for complications like hemorrhagic transformation, requiring regular neurological assessments and blood pressure management. Aspirin administration is delayed for at least 24 hours post-thrombolysis to reduce bleeding risk, unlike in non-thrombolyzed patients where aspirin may begin sooner. Intensive care unit monitoring, including bedside evaluation every hour, is emphasized for thrombolyzed patients to detect any deterioration early. Rehabilitation and secondary prevention measures are tailored similarly but must consider potential contraindications from recent thrombolytic therapy .
The phrase "time is brain" underscores the critical importance of rapid treatment in ischemic stroke management. Brain cells are highly sensitive to ischemia, and irreversible damage can occur within minutes of occlusion. Delays in restoring blood flow can lead to extended brain tissue death, increasing disability and mortality. Therefore, prompt initiation of thrombolysis (ideally within 4.5 hours) significantly improves patient outcomes by minimizing neuronal loss and preserving neurological function . Immediate diagnostic and therapeutic interventions are aimed at reopening blocked vessels swiftly to limit damage .